Meropenem labels and packages: Difference between revisions

Revision as of 01:36, 23 December 2013

Meropenem
MERREM^® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings
Precautions
Adverse Reactions
Overdosage
Clinical Studies
Dosage and Administration
Compatibility, Reconstitution, and Stability
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Labels and packages of MERREM I.V. are provided as follows

Adapted from the FDA Package Insert.

@@ Line 1: / Line 1: @@
 __NOTOC__
 {{Meropenem}}
 {{CMG}}
 ==Labels and Packages==
+Labels and packages of MERREM I.V. are provided as follows
 {|
 |-
@@ Line 45: / Line 43: @@
 {|
 |-
-|[[File:Meropenem brand 7|thumb|400px|left]]
+|[[File:Meropenem brand7.jpg|thumb|400px|left]]
 |-
 |}
@@ Line 77: / Line 75: @@
 |[[File:Meropenem brand12.jpg|thumb|400px|left]]
 |-
-|}<ref>{{Cite web | last = | first = |title = http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/050706s022lbl.pdf | url =http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/050706s022lbl.pdf | publisher = |date = | accessdate = }}</ref>
+|}
 ==References==